NovoPedics
Monmouth Junction, US · 1 known investors
NovoPedics is developing MeniscoFix, a resorbable implant placed via arthroscopically-assisted surgery to replace the entire medial or lateral meniscus of the knee, intended to relieve pain, restore mobility, and prevent osteoarthritis in patients with severe meniscal injuries. The device has received FDA Breakthrough Device Designation and supports the growth of new meniscus-like tissue as it resorbs.
BiotechHealthtechMedical Devices
Founders & leadership
CJ
Charles J. Gatt, Jr., MDFounder & CEO
MG
Michael G. Dunn, PhDFounder & Secretary/Treasurer
KW
Kevin Weadock, PhDChief Operating Officer
Investors · 1
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $275.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.